Experiment 508620

Details

PropertyValue
Pharmacology
Administration routeIV
OrganismEmpty organism
CitationGORDON,M: GURALNIK,M: KANEKO,Y: MIMURA,T: BAKER,M: LANG,W:. (1994). A PHASE I STUDY OF CURDLAN SULFATE-AN HIV INHIBITOR. TOLERANCE, PHARMACOKINETICS AND EFFECTS ON COAGULATION AND ON CD4 LYMPHOCYTES.. 25(3/4)
Amount utilized
Compound isolated
DiseaseSINGLE DOSE GIVEN OVER 4 HOURS. CD4 LEVELS INCREASED IMMEDIATELY. IN HIV-INFECTED PERSONS.
Dose amount3.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitKG
Dose expressionDOSE